{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T21:49:27Z","timestamp":1794433767338,"version":"4.9.1"},"reference-count":88,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T00:00:00Z","timestamp":1726617600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006274","name":"Harvard University Radcliffe Institute for Advanced Study","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["75N93020C00038"],"award-info":[{"award-number":["75N93020C00038"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.vaccine.2024.126324","type":"journal-article","created":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T17:56:08Z","timestamp":1727114168000},"page":"126324","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Social complexity of a fentanyl vaccine to prevent opioid overdose conference proceedings: Radcliffe Institute for Advanced Study conference proceedings"],"prefix":"10.1016","volume":"44","author":[{"given":"Elissa R.","family":"Weitzman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarita","family":"Alegria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur","family":"Caplan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Dowling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl Erik","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayana","family":"Jordan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joe","family":"Kossowsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misia","family":"Landau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi","family":"Larson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ofer","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seth","family":"Mnookin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Reif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy Caryn","family":"Sherman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2024.126324_bb0005","author":"Drug Overdose Deaths in the U.S. Top 100,000 Annually"},{"key":"10.1016\/j.vaccine.2024.126324_bb0010","author":"Synthetic Opioid Overdose Data"},{"issue":"17","key":"10.1016\/j.vaccine.2024.126324_bb0015","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1001\/jama.2018.2844","article-title":"Changes in synthetic opioid involvement in drug overdose deaths in the United States, 2010-2016","volume":"319","author":"Jones","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2024.126324_bb0020","author":"National Vital Statistics System"},{"key":"10.1016\/j.vaccine.2024.126324_bb0025","series-title":"Provisional drug overdose death counts","author":"National Vital Statistics Rapid Release","year":"2022"},{"key":"10.1016\/j.vaccine.2024.126324_bb0030","first-page":"24","article-title":"Introduction to helping to end addiction long-term prevention cooperative: overview and strategies","author":"Ridenour","year":"2023","journal-title":"Prev Sci"},{"issue":"11","key":"10.1016\/j.vaccine.2024.126324_bb0035","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.tips.2018.08.001","article-title":"Immunopharmacotherapies for treating opioid use disorder","volume":"39","author":"Banks","year":"2018","journal-title":"Trends Pharmacol Sci"},{"issue":"6","key":"10.1016\/j.vaccine.2024.126324_bb0040","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1037\/amp0000713","article-title":"Guest editorial: psychologists aim to HEAL the opioid and pain crises","volume":"75","author":"Wandner","year":"2020","journal-title":"Am Psychol"},{"issue":"11","key":"10.1016\/j.vaccine.2024.126324_bb0045","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1517\/13543784.16.11.1775","article-title":"Vaccination against nicotine: an emerging therapy for tobacco dependence","volume":"16","author":"Maurer","year":"2007","journal-title":"Expert Opin Investig Drugs"},{"issue":"4","key":"10.1016\/j.vaccine.2024.126324_bb0050","doi-asserted-by":"crossref","first-page":"200","DOI":"10.4161\/hv.5.4.7310","article-title":"Vaccines against nicotine","volume":"5","author":"Cerny","year":"2009","journal-title":"Hum Vaccin"},{"issue":"5","key":"10.1016\/j.vaccine.2024.126324_bb0055","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2022.2062972","article-title":"COVID-19 vaccine hesitancy: considerations for reluctance and improving vaccine uptake","volume":"18","author":"Parimi","year":"2022","journal-title":"Hum Vaccin Immunother"},{"issue":"4","key":"10.1016\/j.vaccine.2024.126324_bb0060","doi-asserted-by":"crossref","first-page":"200","DOI":"10.4161\/hv.5.4.7310","article-title":"Vaccines against nicotine","volume":"5","author":"Cerny","year":"2009","journal-title":"Hum Vaccin"},{"issue":"11","key":"10.1016\/j.vaccine.2024.126324_bb0065","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14112368","article-title":"Anti-cocaine IgA rather than IgG mediates vaccine protection from cocaine use","volume":"14","author":"Kosten","year":"2022","journal-title":"Pharmaceutics"},{"issue":"25","key":"10.1016\/j.vaccine.2024.126324_bb0070","doi-asserted-by":"crossref","first-page":"8601","DOI":"10.1021\/jacs.7b03334","article-title":"Development of a clinically viable heroin vaccine","volume":"139","author":"Bremer","year":"2017","journal-title":"J Am Chem Soc"},{"issue":"2","key":"10.1016\/j.vaccine.2024.126324_bb0075","doi-asserted-by":"crossref","DOI":"10.1021\/acsptsci.3c00228","article-title":"Multivalent vaccination strategies protect against exposure to Polydrug opioid and stimulant mixtures in mice and rats","volume":"7","author":"Song","year":"2023","journal-title":"ACS Pharmacol Transl Sci"},{"issue":"1","key":"10.1016\/j.vaccine.2024.126324_bb0080","doi-asserted-by":"crossref","DOI":"10.1038\/s42003-024-06390-4","article-title":"Immune profiling of age and adjuvant-specific activation of human blood mononuclear cells in vitro","volume":"7","author":"Sch\u00fcller","year":"2024","journal-title":"Commun Biol"},{"issue":"27","key":"10.1016\/j.vaccine.2024.126324_bb0085","doi-asserted-by":"crossref","first-page":"3747","DOI":"10.1126\/sciadv.adg3747","article-title":"From hit to vial: precision discovery and development of an imidazopyrimidine TLR7\/8 agonist adjuvant formulation","volume":"10","author":"Soni","year":"2024","journal-title":"Sci Adv"},{"key":"10.1016\/j.vaccine.2024.126324_bb0090","article-title":"A systematic review of opioid use disorder and related biomarkers","volume":"12","author":"Bryant","year":"2021","journal-title":"Front Psychol"},{"key":"10.1016\/j.vaccine.2024.126324_bb0095","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.neuroscience.2023.07.031","article-title":"Neuroimmune mechanisms of opioid use disorder and recovery: translatability to human studies, and future research directions","volume":"528","author":"Butelman","year":"2023","journal-title":"Neuroscience"},{"key":"10.1016\/j.vaccine.2024.126324_bb0100","article-title":"The impact of the COVID-19 pandemic on adolescent substance use","author":"Ross","year":"2024","journal-title":"Springer Curr Issues Pediatr"},{"issue":"50","key":"10.1016\/j.vaccine.2024.126324_bb0105","doi-asserted-by":"crossref","DOI":"10.15585\/mmwr.mm7150a2","article-title":"Drug overdose deaths among persons aged 10\u201319 years \u2014 United States, July 2019\u2013December 2021","volume":"71","author":"Tanz","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"2","key":"10.1016\/j.vaccine.2024.126324_bb0110","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1056\/NEJMp2312084","article-title":"The overdose crisis among U.S. Adolescents","volume":"390","author":"Friedman","year":"2024","journal-title":"N Engl J Med"},{"issue":"29","key":"10.1016\/j.vaccine.2024.126324_bb0115","doi-asserted-by":"crossref","first-page":"940","DOI":"10.15585\/mmwr.mm7129e2","article-title":"Vital signs: drug overdose deaths, by selected sociodemographic and social determinants of health characteristics \u2014 25 states and the District of Columbia, 2019\u20132020","volume":"71","author":"Kariisa","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"10.1016\/j.vaccine.2024.126324_bb0120","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12954-023-00736-7","article-title":"Racial\/ethnic disparities in opioid overdose prevention: comparison of the naloxone care cascade in White, Latinx, and black people who use opioids in new York City","volume":"20","author":"Khan","year":"2023","journal-title":"Harm Reduct J"},{"issue":"3","key":"10.1016\/j.vaccine.2024.126324_bb0125","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1037\/sah0000426","article-title":"Intersectional stigma as a fundamental cause of health disparities: a case study of how drug use stigma intersecting with racism and xenophobia creates health inequities for black and Hispanic persons who use drugs over time","volume":"8","author":"Walters","year":"2023","journal-title":"Stigma Health"},{"issue":"11","key":"10.1016\/j.vaccine.2024.126324_bb0130","doi-asserted-by":"crossref","first-page":"494","DOI":"10.3928\/00485713-20201008-01","article-title":"Systemic racism and substance use disorders","volume":"50","author":"Farahmand","year":"2020","journal-title":"Psychiatr Ann"},{"issue":"9","key":"10.1016\/j.vaccine.2024.126324_bb0135","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1097\/MLR.0000000000000769","article-title":"Harnessing implementation science to increase the impact of health equity research","volume":"55","author":"Chinman","year":"2017","journal-title":"Med Care"},{"issue":"3","key":"10.1016\/j.vaccine.2024.126324_bb0140","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1002\/cpt.2812","article-title":"Disruptive innovations to achieve health equity through healthcare and research transformation","volume":"113","author":"Golden","year":"2023","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.vaccine.2024.126324_bb0145","article-title":"Group-based medical mistrust and care expectations among black patients seeking addiction treatment","volume":"2","author":"Hall","year":"2022","journal-title":"Drug Alcohol Dependence Rep"},{"issue":"5","key":"10.1016\/j.vaccine.2024.126324_bb0150","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.11629","article-title":"Factors associated with racial\/ethnic group-based medical mistrust and perspectives on COVID-19 vaccine trial participation and vaccine uptake in the US","volume":"4","author":"Thompson","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.vaccine.2024.126324_bb0155","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jsat.2015.09.006","article-title":"Treatment access barriers and disparities among individuals with co-occurring mental health and substance use disorders: an integrative literature review","volume":"61","author":"Priester","year":"2016","journal-title":"J Subst Abus Treat"},{"issue":"2","key":"10.1016\/j.vaccine.2024.126324_bb0160","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jval.2020.08.2098","article-title":"Disparities in access to opioid treatment programs and office-based buprenorphine treatment across the rural-urban and area deprivation continua: a US Nationwide small area analysis","volume":"24","author":"Amiri","year":"2021","journal-title":"Value Health"},{"issue":"2","key":"10.1016\/j.vaccine.2024.126324_bb0165","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1080\/10826084.2020.1853775","article-title":"Sexual orientation, social determinants of health, and unmet substance use treatment need: findings from a National Survey","volume":"56","author":"Haney","year":"2020","journal-title":"Subst Use Misuse"},{"key":"10.1016\/j.vaccine.2024.126324_bb0170","article-title":"Improving access to evidence-based medical treatment for opioid use disorder: strategies to address key barriers within the treatment system","volume":"2020","author":"Madras","year":"2020","journal-title":"NAM Perspect"},{"issue":"1","key":"10.1016\/j.vaccine.2024.126324_bb0175","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/her\/7.1.107","article-title":"A meta-analysis of studies of the health belief model with adults","volume":"7","author":"Harrison","year":"1992","journal-title":"Health Educ Res"},{"issue":"5","key":"10.1016\/j.vaccine.2024.126324_bb0180","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1111\/dar.13244","article-title":"Implications of addiction diagnosis and addiction beliefs for public stigma: a cross-national experimental study","volume":"40","author":"Rundle","year":"2021","journal-title":"Drug Alcohol Rev"},{"key":"10.1016\/j.vaccine.2024.126324_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2024.06.049","article-title":"Need for strategic communications and stakeholder engagement to advance acceptability of an overdose preventing vaccine targeting fentanyl","author":"Weitzman","year":"2024","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2024.126324_bb0190","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1177\/2168479018771682","article-title":"Ethical issues in research involving participants with opioid use disorder","volume":"52","author":"Anderson","year":"2018","journal-title":"Ther Innov Regul Sci"},{"issue":"11","key":"10.1016\/j.vaccine.2024.126324_bb0195","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1001\/jamainternmed.2018.3931","article-title":"Estimated costs of pivotal trials for novel therapeutic agents approved by the US Food and Drug Administration, 2015-2016","volume":"178","author":"Moore","year":"2018","journal-title":"JAMA Intern Med"},{"issue":"10","key":"10.1016\/j.vaccine.2024.126324_bb0200","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1080\/14760584.2020.1825944","article-title":"How can a global pandemic affect vaccine hesitancy?","volume":"19","author":"Dub\u00e9","year":"2020","journal-title":"Expert Rev Vaccines"},{"issue":"2","key":"10.1016\/j.vaccine.2024.126324_bb0205","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/s41591-022-02185-4","article-title":"A survey of COVID-19 vaccine acceptance across 23 countries in 2022","volume":"29","author":"Lazarus","year":"2023","journal-title":"Nat Med"},{"issue":"11","key":"10.1016\/j.vaccine.2024.126324_bb0210","doi-asserted-by":"crossref","DOI":"10.2196\/30642","article-title":"COVID-19 vaccine hesitancy on social media: building a public twitter Data set of Antivaccine content, vaccine misinformation, and conspiracies","volume":"7","author":"Muric","year":"2021","journal-title":"JMIR Public Health Surveill"},{"issue":"3","key":"10.1016\/j.vaccine.2024.126324_bb0215","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/s41562-021-01056-1","article-title":"Measuring the impact of COVID-19 vaccine misinformation on vaccination intent in the UK and USA","volume":"5","author":"Loomba","year":"2021","journal-title":"Nat Hum Behav"},{"key":"10.1016\/j.vaccine.2024.126324_bb0220","series-title":"Identifying strategies to boost COVID-19 vaccine acceptance in the United States","author":"Schmitzberger","year":"2021"},{"issue":"S1","key":"10.1016\/j.vaccine.2024.126324_bb0225","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/1475-6773.13910","article-title":"Co-creating a theory of change to advance COVID-19 testing and vaccine uptake in underserved communities","volume":"57","author":"Stadnick","year":"2022","journal-title":"Health Serv Res"},{"key":"10.1016\/j.vaccine.2024.126324_bb0230","doi-asserted-by":"crossref","DOI":"10.3389\/frhs.2023.1208458","article-title":"\u201cWhen you get the HPV vaccine, it will prevent cervical cancer; it will act as a shield\u201d: adolescent girls\u2019 knowledge and perceptions regarding the human papillomavirus vaccine in Zambia","volume":"3","author":"Lubeya","year":"2023","journal-title":"Front Health Services"},{"issue":"1","key":"10.1016\/j.vaccine.2024.126324_bb0235","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2023.2214054","article-title":"Parents\u2019 stigmatizing beliefs about the HPV vaccine and their association with information seeking behavior and vaccination communication behaviors","volume":"19","author":"McKenzie","year":"2023","journal-title":"Hum Vaccin Immunother"},{"issue":"Supplement_1","key":"10.1016\/j.vaccine.2024.126324_bb0240","doi-asserted-by":"crossref","first-page":"S98","DOI":"10.1093\/cid\/ciac344","article-title":"Acceptability of a fentanyl vaccine to prevent opioid overdose and need for personalized decision-making","volume":"75","author":"Weitzman","year":"2022","journal-title":"Clin Infect Dis"},{"issue":"16","key":"10.1016\/j.vaccine.2024.126324_bb0245","doi-asserted-by":"crossref","first-page":"3592","DOI":"10.1016\/j.vaccine.2024.04.068","article-title":"Predicting vaccination hesitancy: the role of basic needs satisfaction and institutional trust","volume":"42","author":"Marinthe","year":"2024","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2024.126324_bb0250","doi-asserted-by":"crossref","DOI":"10.1186\/s12889-022-14852-9","article-title":"Messaging preferences among Florida caregivers participating in focus groups who had not yet accepted the HPV vaccine for their 11- to 12-year-old child","volume":"22","author":"Staras","year":"2022","journal-title":"BMC Public Health"},{"issue":"4","key":"10.1016\/j.vaccine.2024.126324_bb0255","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1037\/tra0000511","article-title":"Association between posttraumatic stress disorder and nonfatal drug overdose","volume":"12","author":"Lee","year":"2020","journal-title":"Psychol Trauma"},{"key":"10.1016\/j.vaccine.2024.126324_bb0260","doi-asserted-by":"crossref","DOI":"10.7759\/cureus.11058","article-title":"Recreational Cannabis use and risk of prescription opioid overdose: insights from pediatric inpatients","author":"Pankaj","year":"2020","journal-title":"Cureus"},{"issue":"1","key":"10.1016\/j.vaccine.2024.126324_bb0265","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/add.15580","article-title":"Prevalence of co-occurring mental illness and substance use disorder and association with overdose: a linked data cohort study among residents of British Columbia, Canada","volume":"117","author":"Keen","year":"2022","journal-title":"Addiction"},{"key":"10.1016\/j.vaccine.2024.126324_bb0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2019.107734","article-title":"Between- and within-person associations between opioid overdose risk and depression, suicidal ideation, pain severity, and pain interference","volume":"206","author":"Cleland","year":"2020","journal-title":"Drug Alcohol Depend"},{"issue":"7","key":"10.1016\/j.vaccine.2024.126324_bb0275","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1017\/S003329172300332X","article-title":"Independent and joint contributions of physical disability and chronic pain to incident opioid use disorder and opioid overdose among Medicaid patients","volume":"54","author":"Hoffman","year":"2024","journal-title":"Psychol Med"},{"key":"10.1016\/j.vaccine.2024.126324_bb0280","series-title":"America\u2019s opioid ecosystem: how leveraging system interactions can help curb addiction, overdose, and other harms","article-title":"America\u2019s opioid ecosystem: how leveraging system interactions can help curb addiction, overdose, and other harms","author":"Stein","year":"2023"},{"issue":"6522","key":"10.1016\/j.vaccine.2024.126324_bb0285","first-page":"1274","article-title":"Ensuring vaccine safety: comprehensive safety testing is based on experience with prior vaccines","volume":"370","author":"Knipe","year":"2020","journal-title":"Science (1979)"},{"key":"10.1016\/j.vaccine.2024.126324_bb0290","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.590373","article-title":"Towards precision vaccines: lessons from the second international precision vaccines conference","volume":"11","author":"Soni","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2024.126324_bb0295","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.00171","article-title":"The TLR5 agonist Flagellin shapes phenotypical and functional activation of lung mucosal antigen presenting cells in neonatal mice","volume":"11","author":"Sharma","year":"2020","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2024.126324_bb0300","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/MOP.0000000000000868","article-title":"Toward precision adjuvants: optimizing science and safety","volume":"32","author":"Nanishi","year":"2020","journal-title":"Curr Opin Pediatr"},{"key":"10.1016\/j.vaccine.2024.126324_bb0305","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2020.00332","article-title":"BCG as a case study for precision vaccine development: lessons from vaccine heterogeneity, trained immunity, and immune ontogeny","volume":"11","author":"Angelidou","year":"2020","journal-title":"Front Microbiol"},{"issue":"2","key":"10.1016\/j.vaccine.2024.126324_bb0310","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2018-2752","article-title":"Youth and the opioid epidemic","volume":"143","author":"Levy","year":"2019","journal-title":"Pediatrics"},{"issue":"5","key":"10.1016\/j.vaccine.2024.126324_bb0315","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0156240","article-title":"A screening tool for assessing alcohol use risk among medically vulnerable youth","volume":"11","author":"Levy","year":"2016","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.vaccine.2024.126324_bb0320","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2016-1211","article-title":"Substance use screening, brief intervention, and referral to treatment","volume":"138","author":"Levy","year":"2016","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2024.126324_bb0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2020.108218","article-title":"A feasibility study providing substance use treatment in the Black church","volume":"124","author":"Jordan","year":"2021","journal-title":"J Subst Abus Treat"},{"issue":"2","key":"10.1016\/j.vaccine.2024.126324_bb0330","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1176\/appi.ajp.2021.21040381","article-title":"Surging racial disparities in the U.S. overdose crisis","volume":"179","author":"Friedman","year":"2022","journal-title":"Am J Psychiatry"},{"issue":"6","key":"10.1016\/j.vaccine.2024.126324_bb0335","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1176\/appi.ajp.21100970","article-title":"A new agenda for optimizing investments in community mental health and reducing disparities","volume":"179","author":"Alegria","year":"2022","journal-title":"Am J Psychiatry"},{"issue":"11","key":"10.1016\/j.vaccine.2024.126324_bb0340","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1097\/MLR.0000000000001768","article-title":"Racial\/ethnic disparities in substance use treatment in medicaid managed care in New York City: the role of plan and geography","volume":"60","author":"Alegr\u00eda","year":"2022","journal-title":"Med Care"},{"key":"10.1016\/j.vaccine.2024.126324_bb0345","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.comppsych.2018.12.008","article-title":"Racial\/ethnic differences in 12-month prevalence and persistence of mood, anxiety, and substance use disorders: variation by nativity and socioeconomic status","volume":"89","author":"Vilsaint","year":"2019","journal-title":"Compr Psychiatry"},{"key":"10.1016\/j.vaccine.2024.126324_bb0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.ypmed.2021.106754","article-title":"Examining differences in prescription opioid use behaviors among U.S. adults with and without disabilities","volume":"153","author":"Reif","year":"2021","journal-title":"Prev Med (Baltim)"},{"issue":"2S","key":"10.1016\/j.vaccine.2024.126324_bb0355","article-title":"Substance use and misuse patterns and disability status in the 2020 US National Alcohol Survey: a contributing role for chronic pain","volume":"15","author":"Reif","year":"2022","journal-title":"Disabil Health J"},{"issue":"2S","key":"10.1016\/j.vaccine.2024.126324_bb0360","article-title":"Perspectives of adults with disabilities and opioid misuse: qualitative findings illuminating experiences with stigma and substance use treatment","volume":"15","author":"Ledingham","year":"2022","journal-title":"Disabil Health J"},{"issue":"4","key":"10.1016\/j.vaccine.2024.126324_bb0365","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/ADM.0000000000000847","article-title":"Civil commitment for substance use disorders: a National Survey of addiction medicine physicians","volume":"15","author":"Jain","year":"2021","journal-title":"J Addict Med"},{"key":"10.1016\/j.vaccine.2024.126324_bb0370","series-title":"The urge: Our history of addiction","author":"Fisher","year":"2023"},{"issue":"4","key":"10.1016\/j.vaccine.2024.126324_bb0375","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1016\/S2213-2600(21)00044-8","article-title":"Trial participants\u2019 rights after authorisation of COVID-19 vaccines","volume":"9","author":"Dal-R\u00e9","year":"2021","journal-title":"Lancet Respir Med"},{"issue":"12","key":"10.1016\/j.vaccine.2024.126324_bb0380","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1111\/j.1360-0443.2008.02369.x","article-title":"Denying autonomy in order to create it: the paradox of forcing treatment upon addicts","volume":"103","author":"Caplan","year":"2008","journal-title":"Addiction"},{"key":"10.1016\/j.vaccine.2024.126324_bb0385","series-title":"When medicine went mad: Bioethics and the holocaust","author":"Caplan","year":"2012"},{"issue":"1_Supplement","key":"10.1016\/j.vaccine.2024.126324_bb0390","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.206.Supp.102.09","article-title":"Co-delivery of antigens with TLR7\/8 agonists leads to an improved Th1-mediated immune response to subunit vaccines","volume":"206","author":"Lathrop","year":"2021","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2024.126324_bb0395","series-title":"Stuck: how vaccine rumors start-- and why they don\u2019t go away","author":"Larson","year":"2020"},{"issue":"10255","key":"10.1016\/j.vaccine.2024.126324_bb0400","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/S0140-6736(20)31558-0","article-title":"Mapping global trends in vaccine confidence and investigating barriers to vaccine uptake: a large-scale retrospective temporal modelling study","volume":"396","author":"de Figueiredo","year":"2020","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.vaccine.2024.126324_bb0405","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.1093\/cid\/ciac343","article-title":"Pediatric severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines: perceptions and attitudes from the Food and Drug Administration public commentary","volume":"75","author":"Weitzman","year":"2022","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2024.126324_bb0410","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2021.695807","article-title":"SARS-CoV-2 mRNA vaccine attitudes as expressed in U.S. FDA public commentary: need for a public-private Partnership in a Learning Immunization System","volume":"9","author":"Weitzman","year":"2021","journal-title":"Front Public Health"},{"key":"10.1016\/j.vaccine.2024.126324_bb0415","series-title":"Narratives of human evolution","author":"Landau","year":"1993"},{"key":"10.1016\/j.vaccine.2024.126324_bb0420","series-title":"The panic virus: The true story about the anti-vaccine autism controversy","author":"Mnookin","year":"2012"},{"issue":"7","key":"10.1016\/j.vaccine.2024.126324_bb0425","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1080\/15563650.2022.2042013","article-title":"Pediatric suicides reported to U.S. poison centers","volume":"60","author":"Ross","year":"2022","journal-title":"Clin Toxicol (Phila)"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2024.126324_bb0430","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1093\/cid\/ciac311","article-title":"The impact of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic on substance use in the United States","volume":"75","author":"Ross","year":"2022","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2024.126324_bb0435","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2020-021352","article-title":"Marijuana use to address symptoms and side effects by youth with chronic medical conditions","volume":"147","author":"Kossowsky","year":"2021","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2024.126324_bb0440","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.108276","article-title":"Genome-wide association analysis of opioid use disorder: a novel approach using clinical data","volume":"217","author":"Song","year":"2020","journal-title":"Drug Alcohol Depend"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24010065?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24010065?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T19:47:35Z","timestamp":1735674455000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X24010065"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":88,"alternative-id":["S0264410X24010065"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.126324","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Social complexity of a fentanyl vaccine to prevent opioid overdose conference proceedings: Radcliffe Institute for Advanced Study conference proceedings","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.126324","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"126324"}}